APO RESEARCH · REPORT
Nerve Stimulator
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Product & engineering
Understand the product.
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Selected research
Industry Growth & Trends
Global Nerve Stimulator Industry Growth and Trends Forecast to 2032
Market perspective
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Global Nerve Stimulator key players include Medtronic, Abbott, Boston Scientific, etc. Global top three manufacturers hold a share over 70%.
North America is the largest market, with a share about 80%, followed by China, and Europe, both have a share about 15 percent.
Read the full market overview
In terms of product, Spinal Cord Stimulator is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain Management, followed by Parkinson's Disease, Epilepsy, Incontinence, etc.
Report Scope
This report provides a structured, data-driven view of the global Nerve Stimulator market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Nerve Stimulator market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nerve Stimulator market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nerve Stimulator.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Nerve Stimulator market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Nerve Stimulator Market by Company
Medtronic
Abbott
Boston Scientific
LivaNova
Nevro
Pins Medical
NeuroPace
Synapse Biomedical
Nerve Stimulator Segment by Type
Deep Brain Stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Nerve Stimulator Segment by Application
Pain Management
Parkinson's Disease
Incontinence
Epilepsy
Nerve Stimulator Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nerve Stimulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nerve Stimulator and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nerve Stimulator.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nerve Stimulator manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Nerve Stimulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Vagus Nerve Stimulator
Applications
- Pain Management
- Parkinson's Disease
- Incontinence
- Epilepsy
Companies covered
- Medtronic
- Abbott
- Boston Scientific
- LivaNova
- Nevro
- Pins Medical
- NeuroPace
- Synapse Biomedical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Nerve Stimulator Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Nerve Stimulator Sales Estimates and Forecasts (2021-2032)
- 1.3 Nerve Stimulator Market by Type
- 1.3.1 Deep Brain Stimulator
- 1.3.2 Spinal Cord Stimulator
- 1.3.3 Vagus Nerve Stimulator
- 1.4 Global Nerve Stimulator Market Size by Type
- 1.4.1 Global Nerve Stimulator Market Size Overview by Type (2021-2032)
- 1.4.2 Global Nerve Stimulator Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Nerve Stimulator Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Nerve Stimulator Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Nerve Stimulator Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Nerve Stimulator Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Nerve Stimulator Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Nerve Stimulator Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Nerve Stimulator Industry Trends
- 2.2 Nerve Stimulator Industry Drivers
- 2.3 Nerve Stimulator Industry Opportunities and Challenges
- 2.4 Nerve Stimulator Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Nerve Stimulator Revenue (2021-2026)
- 3.2 Global Top Players by Nerve Stimulator Sales (2021-2026)
- 3.3 Global Top Players by Nerve Stimulator Price (2021-2026)
- 3.4 Global Nerve Stimulator Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nerve Stimulator Major Company Production Sites & Headquarters
- 3.6 Global Nerve Stimulator Company, Product Type & Application
- 3.7 Global Nerve Stimulator Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nerve Stimulator Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nerve Stimulator Players Market Share by Revenue in 2025
- 3.8.3 2025 Nerve Stimulator Tier 1, Tier 2, and Tier 3
4 Nerve Stimulator Regional Status and Outlook
- 4.1 Global Nerve Stimulator Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Nerve Stimulator Historic Market Size by Region
- 4.2.1 Global Nerve Stimulator Sales in Volume by Region (2021-2026)
- 4.2.2 Global Nerve Stimulator Sales in Value by Region (2021-2026)
- 4.2.3 Global Nerve Stimulator Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Nerve Stimulator Forecasted Market Size by Region
- 4.3.1 Global Nerve Stimulator Sales in Volume by Region (2027-2032)
- 4.3.2 Global Nerve Stimulator Sales in Value by Region (2027-2032)
- 4.3.3 Global Nerve Stimulator Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nerve Stimulator by Application
- 5.1 Nerve Stimulator Market by Application
- 5.1.1 Pain Management
- 5.1.2 Parkinson's Disease
- 5.1.3 Incontinence
- 5.1.4 Epilepsy
- 5.2 Global Nerve Stimulator Market Size by Application
- 5.2.1 Global Nerve Stimulator Market Size Overview by Application (2021-2032)
- 5.2.2 Global Nerve Stimulator Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Nerve Stimulator Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Nerve Stimulator Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Nerve Stimulator Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Nerve Stimulator Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Nerve Stimulator Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Nerve Stimulator Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Medtronic
- 6.1.1 Medtronic Company Information
- 6.1.2 Medtronic Business Overview
- 6.1.3 Medtronic Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Medtronic Nerve Stimulator Product Portfolio
- 6.1.5 Medtronic Recent Developments
- 6.2 Abbott
- 6.2.1 Abbott Company Information
- 6.2.2 Abbott Business Overview
- 6.2.3 Abbott Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Abbott Nerve Stimulator Product Portfolio
- 6.2.5 Abbott Recent Developments
- 6.3 Boston Scientific
- 6.3.1 Boston Scientific Company Information
- 6.3.2 Boston Scientific Business Overview
- 6.3.3 Boston Scientific Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Boston Scientific Nerve Stimulator Product Portfolio
- 6.3.5 Boston Scientific Recent Developments
- 6.4 LivaNova
- 6.4.1 LivaNova Company Information
- 6.4.2 LivaNova Business Overview
- 6.4.3 LivaNova Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 LivaNova Nerve Stimulator Product Portfolio
- 6.4.5 LivaNova Recent Developments
- 6.5 Nevro
- 6.5.1 Nevro Company Information
- 6.5.2 Nevro Business Overview
- 6.5.3 Nevro Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Nevro Nerve Stimulator Product Portfolio
- 6.5.5 Nevro Recent Developments
- 6.6 Pins Medical
- 6.6.1 Pins Medical Company Information
- 6.6.2 Pins Medical Business Overview
- 6.6.3 Pins Medical Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pins Medical Nerve Stimulator Product Portfolio
- 6.6.5 Pins Medical Recent Developments
- 6.7 NeuroPace
- 6.7.1 NeuroPace Company Information
- 6.7.2 NeuroPace Business Overview
- 6.7.3 NeuroPace Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 NeuroPace Nerve Stimulator Product Portfolio
- 6.7.5 NeuroPace Recent Developments
- 6.8 Synapse Biomedical
- 6.8.1 Synapse Biomedical Company Information
- 6.8.2 Synapse Biomedical Business Overview
- 6.8.3 Synapse Biomedical Nerve Stimulator Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Synapse Biomedical Nerve Stimulator Product Portfolio
- 6.8.5 Synapse Biomedical Recent Developments
7 North America by Country
- 7.1 North America Nerve Stimulator Sales by Country
- 7.1.1 North America Nerve Stimulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Nerve Stimulator Sales by Country (2021-2026)
- 7.1.3 North America Nerve Stimulator Sales Forecast by Country (2027-2032)
- 7.2 North America Nerve Stimulator Market Size by Country
- 7.2.1 North America Nerve Stimulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Nerve Stimulator Market Size by Country (2021-2026)
- 7.2.3 North America Nerve Stimulator Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Nerve Stimulator Sales by Country
- 8.1.1 Europe Nerve Stimulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Nerve Stimulator Sales by Country (2021-2026)
- 8.1.3 Europe Nerve Stimulator Sales Forecast by Country (2027-2032)
- 8.2 Europe Nerve Stimulator Market Size by Country
- 8.2.1 Europe Nerve Stimulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Nerve Stimulator Market Size by Country (2021-2026)
- 8.2.3 Europe Nerve Stimulator Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Nerve Stimulator Sales by Country
- 9.1.1 Asia-Pacific Nerve Stimulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Nerve Stimulator Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Nerve Stimulator Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Nerve Stimulator Market Size by Country
- 9.2.1 Asia-Pacific Nerve Stimulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Nerve Stimulator Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Nerve Stimulator Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Nerve Stimulator Sales by Country
- 10.1.1 South America Nerve Stimulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Nerve Stimulator Sales by Country (2021-2026)
- 10.1.3 South America Nerve Stimulator Sales Forecast by Country (2027-2032)
- 10.2 South America Nerve Stimulator Market Size by Country
- 10.2.1 South America Nerve Stimulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Nerve Stimulator Market Size by Country (2021-2026)
- 10.2.3 South America Nerve Stimulator Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Nerve Stimulator Sales by Country
- 11.1.1 Middle East and Africa Nerve Stimulator Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Nerve Stimulator Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Nerve Stimulator Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Nerve Stimulator Market Size by Country
- 11.2.1 Middle East and Africa Nerve Stimulator Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Nerve Stimulator Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Nerve Stimulator Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Nerve Stimulator Value Chain Analysis
- 12.1.1 Nerve Stimulator Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Nerve Stimulator Production Mode & Process
- 12.2 Nerve Stimulator Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Nerve Stimulator Distributors
- 12.2.3 Nerve Stimulator Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst